Sunitinib--a new approach following failure of imatinib in patients with advanced gastrointestinal stromal tumor
- PMID: 17426720
- DOI: 10.1038/ncponc0814
Sunitinib--a new approach following failure of imatinib in patients with advanced gastrointestinal stromal tumor
Comment on
-
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.Lancet. 2006 Oct 14;368(9544):1329-38. doi: 10.1016/S0140-6736(06)69446-4. Lancet. 2006. PMID: 17046465 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources